Latest / Biohacking Autism with Nadia Elkhatib.
Leucovorin for Autism? Trial, FRAA & FDA — 24-Min Essentials | John Slattery
A shorter, focused edition of our full John Slattery conversation.
Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism and language impairment, joins Nadia Elkhatib to explain the essential findings in about 24 minutes.
They cover what the trial actually measured, why language and communication mattered, folate receptor alpha autoantibodies (FRAAs), FOLR1, how folate reaches the brain, the reduced folate carrier…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.